Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation/Experiment 1/Signature 1

From BugSigDB
Reviewed Marked as Reviewed by Atrayees on 2023-6-27

Curated date: 2021/01/10

Curator: Michael Lutete

Revision editor(s): WikiWorks, Atrayees

Source: Text, Figure S3, Figure S2

Description: Bacterial species from stool samples that differ between HIV-positive ART-treated Zimbabwean children randomized to continue versus stop cotrimoxazole prophylaxis based on protein families

Abundance in Group 1: increased abundance in continue cotrimoxazole prophylaxis

NCBI Quality ControlLinks
Bacteroides xylanisolvens
Escherichia coli
Odoribacter splanchnicus
Parabacteroides goldsteinii
Parabacteroides johnsonii
Roseburia intestinalis
Alistipes communis

Revision editor(s): WikiWorks, Atrayees